Roivant Sciences (ROIV) Depreciation & Amortization (CF) (2021 - 2025)

Roivant Sciences has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $2.7 million in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 78.57% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (down 78.86% YoY), and the FY2026 full-year result was $3.3 million, down 76.21% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $2.7 million, up from $921000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $16.8 million in Q4 2023, with the low at $921000.0 in Q3 2025.
• Historically, Depreciation & Amortization (CF) has averaged $6.2 million across 5 years, with a median of $4.9 million in 2024.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 205.35% — and 2025, when it slumped 80.98%.
• Roivant Sciences' Depreciation & Amortization (CF) stood at $4.2 million in 2021, then soared by 205.35% to $12.9 million in 2022, then jumped by 30.28% to $16.8 million in 2023, then fell by 24.78% to $12.6 million in 2024, then tumbled by 78.57% to $2.7 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $2.7 million (Q4 2025), $921000.0 (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.